Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

Sanofi Buys OTC Antacid Rolaids from J&J's McNeil-PPC
Paul Quintaro , Benzinga Staff Writer  
January 07, 2013 8:08am   Comments
Share:
Related SNY
Dan Loeb's Activist Campaign Against Nestle Goes Against Decades Of History
Regeneron (REGN) Stock on Fire: What's Behind the Surge?
Good Companies From Warren Buffett's Portfolio (GuruFocus)
Related JNJ
Attention To Details: Neos' ADHD Portfolio
A New ETF For Low Vol ETFs

Sanofi (NYSE : SNY) today announced that its US Consumer Healthcare Division, Chattem, Inc., completed the acquisition of the worldwide rights to the Rolaids^® brand from McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.

Posted-In: News M&A

© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

 

Related Articles (JNJ + SNY)

Attention To Details: Neos' ADHD Portfolio
Dan Loeb's Activist Campaign Against Nestle Goes Against Decades Of History
A New ETF For Low Vol ETFs
Regeneron (REGN) Stock on Fire: What's Behind the Surge?
Dow 30 Stock Roundup: Boeing Bags Big Orders at Paris Air Show; Wal-Mart to Buy Bonobos
Healthcare ETF (IYH) Hits New 52-Week High
View Comments and Join the Discussion!
Sign up for email alerts on SNY
View upcoming Earnings, Ratings, Dividend and Economic Calendars.